Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro
- PMID: 15451189
- PMCID: PMC7126008
- DOI: 10.1016/j.antiviral.2004.05.001
Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro
Abstract
This report describes the application of real-time PCR for testing antivirals against highly pathogenic viruses such as Lassa virus, SARS coronavirus and Ebola virus. The test combines classical cell culture with a quantitative real-time PCR read-out. The assay for Lassa virus was validated with ribavirin, which showed an IC(50) of 9 micrograms/ml. Small-scale screening identified a class of imidazole nucleoside/nucleotide analogues with antiviral activity against Lassa virus. The analogues contained either dinitrile or diester groups at the imidazole 4,5-positions, and many of which possessed an acyclic sugar or sugar phosphonate moiety at the imidazole 1-position. The IC(50) values of the most active compounds ranged from 5 to 21 micrograms/ml. The compounds also inhibited replication of SARS coronavirus and Ebola virus in analogous assays, although to a lesser extent than Lassa virus.
Figures



Similar articles
-
Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.Antiviral Res. 2011 Aug;91(2):89-93. doi: 10.1016/j.antiviral.2011.05.006. Epub 2011 May 17. Antiviral Res. 2011. PMID: 21616094
-
Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.J Virol. 2014 Apr;88(8):4353-65. doi: 10.1128/JVI.03050-13. Epub 2014 Feb 5. J Virol. 2014. PMID: 24501399 Free PMC article.
-
Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.Antiviral Res. 2016 Dec;136:9-18. doi: 10.1016/j.antiviral.2016.10.007. Epub 2016 Oct 19. Antiviral Res. 2016. PMID: 27771389
-
Remdesivir against COVID-19 and Other Viral Diseases.Clin Microbiol Rev. 2020 Oct 14;34(1):e00162-20. doi: 10.1128/CMR.00162-20. Print 2020 Dec 16. Clin Microbiol Rev. 2020. PMID: 33055231 Free PMC article. Review.
-
[Research with the Marburg, Lassa and Ebola viruses].Vopr Virusol. 1993 Mar-Apr;38(2):54-8. Vopr Virusol. 1993. PMID: 8059520 Review. Russian. No abstract available.
Cited by
-
Secondary metabolites of Livistona decipiens as potential inhibitors of SARS-CoV-2.RSC Adv. 2022 Jul 6;12(30):19505-19511. doi: 10.1039/d2ra01306a. eCollection 2022 Jun 29. RSC Adv. 2022. PMID: 35865563 Free PMC article.
-
Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus.Results Chem. 2021 Jan;3:100132. doi: 10.1016/j.rechem.2021.100132. Epub 2021 Apr 22. Results Chem. 2021. PMID: 33907666 Free PMC article. Review.
-
Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.Clin Infect Dis. 2010 Dec 15;51(12):1435-41. doi: 10.1086/657315. Epub 2010 Nov 8. Clin Infect Dis. 2010. PMID: 21058912 Free PMC article. Review.
-
Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms.Bioorg Chem. 2023 Jan;130:106255. doi: 10.1016/j.bioorg.2022.106255. Epub 2022 Nov 17. Bioorg Chem. 2023. PMID: 36403336 Free PMC article.
-
A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.Antiviral Res. 2020 Jan;173:104667. doi: 10.1016/j.antiviral.2019.104667. Epub 2019 Nov 28. Antiviral Res. 2020. PMID: 31786250 Free PMC article.
References
-
- Andrei G., De Clercq E. Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. Antiviral Res. 1990;14:287–299. - PubMed
-
- Andrei G., De Clercq E. Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral Res. 1993;22:45–75. - PubMed
-
- Balzarini J., Vahlenkamp T., Egberink H., Hartmann K., Witvrouw M., Pannecouque C., Casara P., Nave J.F., De Clercq E. Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice. Antimicrob. Agents Chemother. 1997;41:611–616. - PMC - PubMed
-
- Bartolotta S., Garcia C.C., Candurra N.A., Damonte E.B. Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch. Virol. 2001;146:777–790. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous